Cover Image
close this bookSources and Prices of Selected Drugs and Diagnostics for People Living with HIV/AIDS (UNAIDS, 2001, 36 p.)
View the document(introduction...)
View the documentIntroduction
View the documentBackground
View the documentSupply and prices
Open this folder and view contentsInformation on sources and prices of selected drugs and diagnostics
View the documentAnnex I: Offers of donation/price reductions of antiretroviral drugs up to 15 April 2001
View the documentAnnex II: Bulk procurement list for HIV tests
View the documentAnnex III: Manufacturers per therapeutic group included in the price survey (2000)
View the documentAnnex IV: Further information and contacts
Expanding the text here will generate a large amount of data for your browser to display

Annex I: Offers of donation/price reductions of antiretroviral drugs up to 15 April 2001

(both offers made in response to the Expression of Interest launched in October 2000 and publicly announced offers)

Individual drug offers announced

Generic Name

Brand name
(*)

Class

Unit dose
(**)

Daily dose
(***)

Manufacturer

Announced discount price/day (in US$)

Abacavir

Ziagen

NNRTI

300 mg

2 x 300 mg

GlaxoSmithKline

N/A

Abacavir


NNRTI

300 mg

2 x 300 mg

Hetero

10.64

Delavirdine

Rescriptor

NNRTI

100 mg

3 x 400 mg

Upjohn-Pharmacia

N/A

Didanosine (ddI)

Videx

NRTI

100 mg

4 x 100 mg

Bristol-Myers Squibb

0.85

Didanosine (ddI)


NRTI

100 mg

4 x 100 mg

Cipla

1.60

Didanosine (ddI)


NRTI

100 mg

4 x 100 mg

Aurobindo

0.52

Efavirenz

Stocrin/Sustiva

NNRTI

200 mg

3 x 200 mg

Merck/Dupont

1.37

Efavirenz

Stocrin/Sustiva

NNRTI

200 mg

3 x 200 mg

Merck/Dupont (for Brazil)

2.52

Efavirenz


NNRTI

200 mg

3 x 200 mg

Hetero

3.23

Efavirenz


NNRTI

200 mg

3 x 200 mg

Aurobindo

1.33

Indinavir

Crixivan

PI

400 mg

6 x 400 mg

Merck

1.64

Indinavir

Crixivan

PI

400 mg

6 x 400 mg

Merck (for Brazil)

2.82

Indinavir


PI

400 mg

6 x 400 mg

Hetero

6.30

Indinavir


PI

400 mg

6 x 400 mg

Cipla

5.04

Lamivudine (3TC)

Epivir

NRTI

150 mg

2 x 150 mg

GlaxoSmithKline

0.63

Lamivudine (3TC)


NRTI

150 mg

2 x 150 mg

Hetero

0.27

Lamivudine (3TC)

Lamivir

NRTI

150 mg

2 x 150 mg

Cipla (to not-for-profit programmes)

0.30

Lamivudine (3TC)


NRTI

150 mg

2 x 150 mg

Aurobindo

0.25

Nelfinavir

Viracept

PI

250 mg

9 x 250 mg

Roche

9.891

Nelfinavir


PI

250 mg

9 x 250 mg

Hetero

6.16

Nevirapine

Viramune

NNRTI

100 mg

2 x 200 mg

Boehringer Ingelheim

Free of charge for MTCT only 1.22 for adult treatment

Nevirapine


NNRTI

200 mg

2 x 200 mg

Hetero

0.55

Nevirapine

Nevimune

NNRTI

200 mg

2 x 200 mg

Cipla (to not-for-profit programmes)

0.54






Cipla (for Uganda)

0.80

Ritonavir

Norvir

PI

600 mg

2 x 600 mg

Abbott

N/A

Ritonavir


PI

100 mg

12 x 100 mg

Hetero

11.78

Saquinavir softgel

Fortovase

PI

200 mg

9 x 200 mg

Roche

6.582

Saquinavir softgel


PI

200 mg

9 x 200 mg

Hetero

2.72

Saquinavir hardgel

Invirase

PI

200 mg

9 x 200 mg

Roche

11.92

Saquinavir hardgel


PI

200 mg

9 x 200 mg

Aurobindo

6.78

Stavudine (d4T)

Zerit

NRTI

40 mg

2 x 40 mg

Bristol-Myers Squibb

0.15

Stavudine (d4T)


NRTI

50 mg

2 x 50 mg

Hetero

0.13

Stavudine (d4T)

Stavir

NRTI

40 mg

2 x 40 mg

Cipla (to not-for-profit programmes)

0.11

Stavudine (d4T)


NRTI

50 mg

2 x 40 mg

Aurobindo

0.13

Zalcitabine (ddC)

Hivid

NRTI

0.75 mg

3 x 0.75 mg

Roche

3.90

Zalcitabine (ddC)


NRTI

0.75 mg

3 x 0.75 mg

Hetero

0.12

Zidovudine (ZDV)

Retrovir

NRTI

250 mg

2 x 250 mg

GlaxoSmithKline

1.49

Zidovudine (ZDV)


NRTI

200 mg

2 x 200 mg

Hetero

0.53

Zidovudine (ZDV)

Zidovir

NRTI

300 mg

2 x 300 mg

Cipla

0.84

Zidovudine (ZDV)


NRTI

100 mg

6 x 100 mg

Aurobindo

0.50

Combination offers announced

Lamivudine, zidovudine and nevirapine

Generic triple therapy


Cipla (to not-for-profit programmes + Nigeria)

0.96

Lamivudine, zidovudine and nevirapine

Generic triple therapy


CIPLA offer to Governments

1.64

Lamivudine, zidovudine and nevirapine

Generic triple therapy


Aurobindo offer to Governments

0.81

Lamivudine, stavudine and nevirapine

Generic triple therapy


Hetero offer to Governments

0.95

Lamivudine+zidovudine (Combivir)

NRTI

150 mg + 300 mg

2 x 1 tab

GlaxoSmithKline (for developing countries)

2.00

Lamivudine+zidovudine (Duovir)

NRTI

150 mg + 300 mg

2 x 1 tab

CIPLA (for Uganda)

1.52

(*) Brand names may vary between countries

NNRTI = Non Nucleoside Reverse Transcriptase Inhibitors

(**) Other unit doses may exist

NRTI = Nucleoside Reverse Transcriptase Inhibitors

(***) Adult dose

PI = Protease Inhibitors

1 For each single pack purchased, one extra pack is delivered free of charge (for Sub-Saharan Africa only).

2 For every 100 packs purchased, 15 extra packs delivered free of charge (for Sub-Saharan Africa only).